Total number of projects: 4
As coordinator: 0
As participant: 3
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 100.000 | 0 | 100.000 | 1 | ||
2012 | 0 | 2.999.300 | 363.600 | 1 | ||
2011 | 0 | 5.999.213 | 289.920 | 1 | ||
2010 | 0 | 1.979.200 | 1.979.200 | 1 |
Total number of partners: 120
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 117
Frequent / Rare Partner Ratio: 0.03
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-08-01 | IMMUNE RESPONSES TO INFLUENZA VACCINE | IRINVAC | coordinator | 100.000 | 1 |
2012-01-01 | TargetIng novel MEchanisms of Resolution in inflammation | TIMER | participant | 2.999.300 | 13 |
2011-09-01 | International Research Consortium on Dengue Risk Assessment, Management, and Surveillance | IDAMS | participant | 5.999.213 | 18 |
2010-09-01 | New approaches to analyze and exploit the human B and T cell response against viruses | IMMUNEXPLORE | participant | 1.979.200 | 1 |